Evogene Ltd (EVGN) — RQD Stock Rating Cockpit

$0.38 +1.60% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.38

Evogene Ltd (EVGN) carries a Roarable Rating of C- (Hold) with 59/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C- • HOLD / WATCH Cap $6.0M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $0.38 (+0.10%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 59/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.2% avg 90D alpha vs SPY • 53.1% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERHOLD / WATCH • C-
025507510059
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C- · Rk D+
Cash (12)Whales (15)SEC (13)Macro (10)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE+0% Base Target
$1 Bull$0 Base$0 Bear
📬 FREE EVGN RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for EVGN)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (59/100 Composite)
🔍 WHY EVGN SCORES 59/100 (C-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+15/20 pts (25% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (22% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
51
Grade C-$0.38+2.6% Next Q
Q2 (-2Q)
54
Grade C-$0.39-7.7% Next Q
Q3 (-1Q)
56
Grade C$0.36+5.6% Next Q
Current
59
Grade C-$0.38+0.2% Hist 90D α
Trajectory: C- (51) → C- (59)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the EVGN Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 59/100 (C-) score, EVGN faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($0.45) or 200D SMA ($0.66) invalidates the momentum regime and cuts Target Base ($0.38) toward Bear Floor ($0.30).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $EVGN• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “EVGN Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”
RSI-14 MOMENTUMNEUTRAL RANGE
41.530 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.80>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
7 / 99-Pt Accounting
52-WEEK LASER RANGE3% OF RANGE
L: $0$0.38H: $1
1. Money & Cash Health● MIXED
Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: C-RQD 12 / 20
2. Big Money & Insiders● NEUTRAL
Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: C-RQD 24 / 40
3. Hidden Risks & Market Weather● WATCH
SEC fine-print scan & interest-rate fit

No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.

Factor Grade: D+RQD 23 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on EVGN

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
NEUTRAL (60)

14.0% ROIC with 42.0% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
NEUTRAL (65)

Altman-Z 4.20 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
NEUTRAL (57)

24/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like EVGN
  • ✓Big institutional funds and options desks are actively positioning on the bullish side.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (EVGN Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
EVGN // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -51.28%🛡️ HOLDING TREND SUPPORT
2026-10-30O $0.38H $0.38L $0.37C $0.38VOL 14.7K
RES: $0.75SUP: $0.35SMA50: $0.45SMA200: $0.66
$1.13$0.92$0.71$0.50$0.28RES $0.75SUP $0.35$0.382026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

EVGN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on EVGN today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for EVGN. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for EVGN today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (EVGN)

Materials Rank #70 of 270 ⚔️ SNES vs EVGN Full Matrix →

1. Head-to-Head Materials Peer Comparison (EVGN vs. SNES, FRTT, NXTS, AVD)

Industry: Agricultural Chemicals (11 Tracked Issuers)

Across 270 tracked Materials securities in the Roarable RQD universe, Evogene Ltd (EVGN) ranks #70 by composite RQD confidence (59/100, grade C-) and #264 by equity capitalization ($6.0M). Within this direct 5-issuer industry benchmark cohort, EVGN leads on earnings valuation at N/A trailing P/E, while AVD leads on capital efficiency and profitability with -6.1% ROIC and 28.6% gross margin. EVGN currently leads its immediate peer cohort in composite quantitative strength at 59/100 (C-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
EVGN ACTIVE
Evogene Ltd
C- 59/100 — — — +1.60% $6.0M Benchmark Subject
SNES
SenesTech Inc.
D 45/100 — 62.5% -35.0% +4.12% $5.5M /snes-vs-evgn →
FRTT
Fort Technology Inc.
D+ 56/100 — — — -3.14% $8.1M /frtt-vs-evgn →
NXTS
Nexentis Technologies Inc.
D- 42/100 — — -27.4% +0.40% $1.9M /nxts-vs-evgn →
AVD
American Vanguard Corporation ($0.10 Par Value)
D- 35/100 — 28.6% -6.1% -3.51% $32.5M /avd-vs-evgn →

2. EVGN Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

Evogene Ltd (EVGN) operates in Agricultural Chemicals (Materials) with an equity capitalization of $6.0M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. EVGN Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is EVGN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Evogene Ltd (NASDAQ: EVGN) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 59/100 at a spot price of $0.38 (+1.60% 1D, market cap $6.0M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 270 tracked Materials issuers, EVGN ranks #70 in composite RQD confidence.

How does EVGN compare to SNES and FRTT in the Materials sector?

Within the Materials sector (Agricultural Chemicals), EVGN carries a Roarable C- (59/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, SNES (SenesTech Inc.) holds a D grade (45/100 RQD, P/E N/A, ROIC -35.0%, cap $5.5M) and FRTT (Fort Technology Inc.) posts a D+ grade (56/100 RQD, P/E N/A, ROIC —, cap $8.1M). Among the 5-stock peer group, EVGN leads on earnings multiple (N/A) while AVD leads on capital efficiency (-6.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for EVGN?

For Evogene Ltd (EVGN), key quantitative strengths include Big institutional funds and options desks are actively positioning on the bullish side. and sector rank #70 in Materials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is EVGN trading relative to its 50-day, 200-day, and 52-week technical levels?

EVGN last traded at $0.38 (+1.60% on volume of 13,847 shares), positioning the stock -15.56% below its 50-day simple moving average ($0.45) and -42.42% below its 200-day simple moving average ($0.66). Across its 52-week range of $0.35 to $1.28, EVGN sits at the 3.2% percentile with a 14-day RSI of 41.5 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.43).

EVGN Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell EVGN stock right now?

Evogene Ltd (EVGN) currently earns a Roarable Rating of C- (Hold — HOLD) with 59/100 RQD Confidence. Solid steady margins (steady margins), mixed timing at current multiples—hold if owned, no rush to chase.

What is EVGN's 12-month price target and RQD AI Jury consensus?

EVGN's 12-month base price target is $0.38 (range $0.3 to $1.34), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%